Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on May 18, 2026 by admin

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

Conditions: Major Depressive Disorder

Interventions: Device: Motif XCS System

Sponsors: Motif Neurotech, Inc.; Bright Research Partners

Not yet recruiting
CategoriesClinicalTrials.gov TagsAcademic research, Depression, Medical device, News Approved

Post navigation

Previous PostPrevious A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Next PostNext Assessing the Effects of Cool Roofs on Indoor Environments and Health in Tavua, Fiji
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.